Balance Sheet Data

AbbVie Inc. (ABBV)

$158.02

+2.72 (+1.75%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 8,06139,9248,4799,8309,22926,540.6230,870.1235,905.8941,763.1348,575.85
Total Cash (%)
Account Receivables 5,3845,4288,8229,97711,25412,040.1714,004.2616,288.7418,945.8822,036.47
Account Receivables (%)
Inventories 1,6051,8133,3103,1283,5793,957.984,603.635,354.616,228.107,244.07
Inventories (%)
Accounts Payable 1,5461,4522,2762,8822,784.033,238.193,766.424,380.835,095.475,926.68
Accounts Payable (%)
Capital Expenditure -638-552-798-787-695-1,073.24-1,248.31-1,451.95-1,688.80-1,964.29
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.